Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Simen Svendsen Vatn, Jonas Christoffer Lindstrøm, Aina E F Moen, Stephan Brackmann, Tone M Tannæs, Christine Olbjørn, Daniel Bergemalm, Åsa V Keita, Fernando Gomollon, Trond Espen Detlie, Torben Lüders, Rahul Kalla, Alex Adams, Jack Satsangi, Jørgen Jahnsen, Morten H Vatn, Jonas Halfvarson, Petr Ricanek & Hilde Nilsen. (2022) Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort. Clinical and Experimental Gastroenterology 15, pages 5-25.
Read now
Read now
Chun-Chang Ho, Giha Kim, Chin Hee Mun, Ju-Won Kim, Jieun Han, Ji Yoon Park, Yong-Beom Park & Sang-Kyou Lee. (2021) Transcriptional Interactomic Inhibition of RORα Suppresses Th17-Related Inflammation. Journal of Inflammation Research 14, pages 7091-7105.
Read now
Read now
Ikram Mezghiche, Hanane Yahia-Cherbal, Lars Rogge & Elisabetta Bianchi. (2021) Novel approaches to develop biomarkers predicting treatment responses to TNF-blockers. Expert Review of Clinical Immunology 17:4, pages 331-354.
Read now
Read now
Hu Zhang, Zhen Zeng, Arjudeb Mukherjee & Bo Shen. (2018) Molecular diagnosis and classification of inflammatory bowel disease. Expert Review of Molecular Diagnostics 18:10, pages 867-886.
Read now
Read now
Samuele Naviglio, Paolo Giuffrida, Gabriele Stocco, Marco Vincenzo Lenti, Alessandro Ventura, Gino Roberto Corazza & Antonio Di Sabatino. (2018) How to predict response to anti-tumour necrosis factor agents in inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 12:8, pages 797-810.
Read now
Read now
Rahil Dahlén, Maria K Magnusson, Antal Bajor, Anders Lasson, Kjell-Arne Ung, Hans Strid & Lena Öhman. (2015) Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy. Scandinavian Journal of Gastroenterology 50:9, pages 1118-1126.
Read now
Read now
Renathe Rismo, Trine Olsen, Guanglin Cui, Eyvind J. Paulssen, Ingrid Christiansen, Knut Johnsen, Jon Florholmen & Rasmus Goll. (2013) Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease. Scandinavian Journal of Gastroenterology 48:3, pages 311-319.
Read now
Read now
Guanglin Cui, Aping Yuan, Rasmus Goll & Jon Florholmen. (2012) IL-17A in the tumor microenvironment of the human colorectal adenoma–carcinoma sequence. Scandinavian Journal of Gastroenterology 47:11, pages 1304-1312.
Read now
Read now
Renathe Rismo, Trine Olsen, Guanglin Ciu, Eyvind J. Paulssen, Ingrid Christiansen, Jon Florholmen & Rasmus Goll. (2012) The effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's disease. Scandinavian Journal of Gastroenterology 47:10, pages 1200-1210.
Read now
Read now
Articles from other publishers (54)
Giorgio Guglielmi, Stefania Crucitta, Lorenzo Bertani, Martina Ruglioni, Giovanni Baiano Svizzero, Linda Ceccarelli, Marzia Del Re, Romano Danesi, Francesco Costa & Stefano Fogli. (2023) Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn’s Disease Treated With Anti-TNF-α Biologics. Inflammatory Bowel Diseases.
Crossref
Crossref
Giacomo Cozzi, Laura Scagnellato, Mariagrazia Lorenzin, Edoardo Savarino, Fabiana Zingone, Francesca Ometto, Marta Favero, Andrea Doria, Stephan R. Vavricka & Roberta Ramonda. (2023) Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies. Nature Reviews Rheumatology 19:8, pages 503-518.
Crossref
Crossref
Hui Cao, Jun Diao, Huosheng Liu, Suxian Liu, Jun Liu, Jianye Yuan & Jiang Lin. (2023) The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 29:5, pages 818-829.
Crossref
Crossref
Sophie Vieujean & Edouard Louis. (2023) Precision medicine and drug optimization in adult inflammatory bowel disease patients. Therapeutic Advances in Gastroenterology 16, pages 175628482311733.
Crossref
Crossref
Joelynn Dailey & Jeffrey S. Hyams. 2023. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
103
111
.
SUSAN D Ghiassian, IVAN VOITALOV, JOHANNA B WITHERS, MARC SANTOLINI, ALIF SALEH & VIATCHESLAV R AKMAEV. (2022) Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis. Translational Research 246, pages 78-86.
Crossref
Crossref
Guanglin Cui, Jon Florholmen & Rasmus Goll. (2022) Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?. Frontiers in Immunology 13.
Crossref
Crossref
Hiroshi Nakase, Noriko Sato, Naomi Mizuno & Yoshiko Ikawa. (2022) The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmunity Reviews 21:3, pages 103017.
Crossref
Crossref
Susan D. Ghiassian, Johanna B. Withers, Marc Santolini, Alif Saleh & Viatcheslav R. Akmaev. (2022) RETRACTED: Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis. Translational Research 239, pages 35-43.
Crossref
Crossref
Yang Wu, Amy Wen, Shane P Selvanderan, Wei Xuan, Jane M Andrews, Jenn H Koo, Astrid-Jane Williams, Watson Ng & Susan Connor. (2021) Management Decisions in Crohn’s Disease Are Changed by Knowledge of Proactive and Reactive Testing of Antitumor Necrosis Factor Drug Levels. Crohn's & Colitis 360 3:3.
Crossref
Crossref
Run-Feng Zhang, Shuang Liu, Yun-Wei WangJi Li. (2021) Potential molecular biomarkers used to predict the response to biological therapies in ulcerative colitis. Chinese Medical Journal 134:9, pages 1058-1060.
Crossref
Crossref
Guanglin Cui, Qingbo Fan, Zhenfeng Li, Rasmus Goll & Jon Florholmen. (2021) Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers. eBioMedicine 66, pages 103329.
Crossref
Crossref
Raja Atreya, Markus F. Neurath & Britta Siegmund. (2020) Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?. Frontiers in Medicine 7.
Crossref
Crossref
Mitchell R. K. L. Lie, Emma Paulides & C. Janneke van der Woude. (2020) Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse events. International Journal of Colorectal Disease 35:8, pages 1489-1500.
Crossref
Crossref
Javier P Gisbert & María Chaparro. (2020) Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice. Journal of Crohn's and Colitis 14:5, pages 694-709.
Crossref
Crossref
Guoqing Hou & Shrinivas Bishu. (2020) Th17 Cells in Inflammatory Bowel Disease: An Update for the Clinician. Inflammatory Bowel Diseases 26:5, pages 653-661.
Crossref
Crossref
Alessia Butera, Monica Di Paola, Francesco Vitali, Daniela De Nitto, Francesco Covotta, Francesco Borrini, Roberta Pica, Carlotta De Filippo, Duccio Cavalieri, Alessandro Giuliani, Annamaria Pronio & Monica Boirivant. (2020) IL-13 mRNA Tissue Content Identifies Two Subsets of Adult Ulcerative Colitis Patients With Different Clinical and Mucosa-Associated Microbiota Profiles. Journal of Crohn's and Colitis 14:3, pages 369-380.
Crossref
Crossref
Zhen Qin, Peng-Yuan Wang, Jing-Jing Wan, Yu Zhang, Jie Wei, Yang Sun & Xia Liu. (2020) MicroRNA124-IL6R Mediates the Effect of Nicotine in Inflammatory Bowel Disease by Shifting Th1/Th2 Balance Toward Th1. Frontiers in Immunology 11.
Crossref
Crossref
Lorenzo Bertani, Luca Antonioli, Matteo Fornai, Gherardo Tapete, Giovanni Baiano Svizzero, Santino Marchi, Corrado Blandizzi & Francesco Costa. (2020) Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases. Minerva Gastroenterologica e Dietologica 65:4.
Crossref
Crossref
Heike Schmitt, Ulrike Billmeier, Walburga Dieterich, Timo Rath, Sophia Sonnewald, Stephen Reid, Simon Hirschmann, Kai Hildner, Maximilian J Waldner, Jonas Mudter, Arndt Hartmann, Robert Grützmann, Clemens Neufert, Tino Münster, Markus F Neurath & Raja Atreya. (2019) Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn’s disease. Gut 68:5, pages 814-828.
Crossref
Crossref
Joseph Diab, Rania Al-Mahdi, Sandra Gouveia-Figueira, Terkel Hansen, Einar Jensen, Rasmus Goll, Thomas Moritz, Jon Florholmen & Guro Forsdahl. (2019) A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naïve and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression. Inflammatory Bowel Diseases 25:3, pages 490-497.
Crossref
Crossref
Ryan Ungaro & Judy Cho. 2019. Biomarkers in Inflammatory Bowel Diseases. Biomarkers in Inflammatory Bowel Diseases
333
341
.
Raja Atreya & Markus F Neurath. (2018) Mechanisms of molecular resistance and predictors of response to biological therapy in inflammatory bowel disease. The Lancet Gastroenterology & Hepatology 3:11, pages 790-802.
Crossref
Crossref
Shi-xue Dai, Hong-xiang Gu, Qian-yi Lin, Shao-zhuo Huang, Tiao-si Xing, Qing-fang Zhang, Gang Wu, Min-hua Chen, Wan-er Tan, Hong-jian Jian, Zhong-wen Zheng, Tao Zhong, Min-hai Zhang, Xing-fang Cheng, Peng Huang, Guang-jie Liao & Wei-hong Sha. (2017) CD8 + CD28 + /CD8 + CD28 − T cell equilibrium can predict the active stage for patients with inflammatory bowel disease. Clinics and Research in Hepatology and Gastroenterology 41:6, pages 693-702.
Crossref
Crossref
Loris Lopetuso, Viviana Gerardi, Valerio Papa, Franco Scaldaferri, Gian Rapaccini, Antonio Gasbarrini & Alfredo Papa. (2017) Can We Predict the Efficacy of Anti-TNF-α Agents?. International Journal of Molecular Sciences 18:9, pages 1973.
Crossref
Crossref
Michael J. Rosen, Rebekah Karns, Jefferson E. Vallance, Ramona Bezold, Amanda Waddell, Margaret H. Collins, Yael Haberman, Phillip Minar, Robert N. Baldassano, Jeffrey S. Hyams, Susan S. Baker, Richard Kellermayer, Joshua D. Noe, Anne M. Griffiths, Joel R. Rosh, Wallace V. Crandall, Melvin B. Heyman, David R. Mack, Michael D. Kappelman, James Markowitz, Dedrick E. Moulton, Neal S. Leleiko, Thomas D. Walters, Subra Kugathasan, Keith T. Wilson, Simon P. Hogan & Lee A. Denson. (2017) Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn’s Disease in Treatment-Naive Pediatric Patients. Gastroenterology 152:6, pages 1345-1357.e7.
Crossref
Crossref
Peter Townsend & Jeffrey S. Hyams. 2017. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
95
101
.
Casper Steenholdt, Klaus Bendtzen, Jørn Brynskov & Mark A. Ainsworth. (2016) Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies. Inflammatory Bowel Diseases 22:8, pages 1999-2015.
Crossref
Crossref
Terez Shea-Donohue, Alessio Fasano, Aiping Zhao, Luigi Notari, Shu Yan, Rex Sun, Jennifer A. Bohl, Neemesh Desai, Greg Tudor, Motoko Morimoto, Catherine Booth, Alexander Bennett, Ann M. Farese & Thomas J. MacVittie. (2016) Mechanisms Involved in the Development of the Chronic Gastrointestinal Syndrome in Nonhuman Primates after Total-Body Irradiation with Bone Marrow Shielding. Radiation Research 185:6, pages 591-603.
Crossref
Crossref
Sofia Roth, Marianne R. Spalinger, Claudia Gottier, Luc Biedermann, Jonas Zeitz, Silvia Lang, Achim Weber, Gerhard Rogler & Michael Scharl. (2016) Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative Colitis. PLOS ONE 11:5, pages e0154817.
Crossref
Crossref
Casper Steenholdt, Mehmet Coskun, Sine Buhl, Klaus Bendtzen, Mark A. Ainsworth, Jørn Brynskov & Ole H. Nielsen. (2016) Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease. Medicine 95:16, pages e3417.
Crossref
Crossref
Tadakazu Hisamatsu, Ulrike Erben & Anja A. Kühl. (2016) The Role of T-Cell Subsets in Chronic Inflammation in Celiac Disease and Inflammatory Bowel Disease Patients: More Common Mechanisms or More Differences?. Inflammatory Intestinal Diseases 1:2, pages 52-62.
Crossref
Crossref
Lijun Du, John J. Kim, Jinhua Shen & Ning Dai. (2016) Crosstalk between Inflammation and ROCK/MLCK Signaling Pathways in Gastrointestinal Disorders with Intestinal Hyperpermeability. Gastroenterology Research and Practice 2016, pages 1-9.
Crossref
Crossref
Johan Burisch & Pia Munkholm. 2016. Telemanagement of Inflammatory Bowel Disease. Telemanagement of Inflammatory Bowel Disease
85
99
.
Dingguo Zhang, Cheng Wei, Jun Yao, Xiaoyan Cai & Lisheng Wang. (2015) Interleukin-10 gene-carrying bifidobacteria ameliorate murine ulcerative colitis by regulating regulatory T cell/T helper 17 cell pathway. Experimental Biology and Medicine 240:12, pages 1622-1629.
Crossref
Crossref
Stephanie M. Slevin & Laurence J. Egan. (2015) New Insights into the Mechanisms of Action of Anti–Tumor Necrosis Factor-α Monoclonal Antibodies in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 21:12, pages 2909-2920.
Crossref
Crossref
Aping Yuan, Hang Yang, Haili Qi, Jing Cui, Wei Hua, Can Li, Zhigang Pang, Wei Zheng & Guanglin Cui. (2015) IL-9 antibody injection suppresses the inflammation in colitis mice. Biochemical and Biophysical Research Communications 468:4, pages 921-926.
Crossref
Crossref
Shoko Sato, Toshimi Chiba, Shotaro Nakamura & Takayuki Matsumoto. (2015) Changes in cytokine profile may predict therapeutic efficacy of infliximab in patients with ulcerative colitis. Journal of Gastroenterology and Hepatology 30:10, pages 1467-1472.
Crossref
Crossref
M. K. Magnusson, H. Strid, S. Isaksson, A. Bajor, A. Lasson, K.‐A. Ung & L. Öhman. (2015)
Cultured blood T‐cell responses predict anti‐
TNF
therapy response in patients with ulcerative colitis
. Alimentary Pharmacology & Therapeutics 41:11, pages 1149-1161.
Crossref
Crossref
Emilio G Quetglas. (2015) Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease. World Journal of Gastroenterology 21:44, pages 12519.
Crossref
Crossref
Konstantinos Papamichael, Ann Gils, Paul Rutgeerts, Barrett G. Levesque, Séverine Vermeire, William J. Sandborn & Niels Vande Casteele. (2015) Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD. Inflammatory Bowel Diseases 21:1, pages 182-197.
Crossref
Crossref
Haili Qi, Hang Yang, Gang Xu, Jingli Ren, Wei Hua, Yingpeng Shi, Malvin Torsvik, Jon Florholmen & Guanglin Cui. (2015) Therapeutic efficacy of IL-17A antibody injection in preventing the development of colitis associated carcinogenesis in mice. Immunobiology 220:1, pages 54-59.
Crossref
Crossref
Ting Wen & Marc E. Rothenberg. 2015. Mucosal Immunology. Mucosal Immunology
883
914
.
Florian Martin, Alain Sewer, Marja Talikka, Yang Xiang, Julia Hoeng & Manuel C Peitsch. (2014) Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models. BMC Bioinformatics 15:1.
Crossref
Crossref
Jung-Wook Kim, Hyo Jong Kim, Chang Kyun Lee, Jae-Jun Shim, Jae Young Jang, Suk Ho Dong, Byung-Ho Kim, Young Woon Chang & Sung-Gil Chi. (2014) Elevation of PRKCDBP, A Novel Transcriptional Target of TNF-α, and Its Downregulation by Infliximab in Patients with Ulcerative Colitis. Digestive Diseases and Sciences 59:12, pages 2947-2957.
Crossref
Crossref
Geert R. D'Haens, R. Balfour Sartor, Mark S. Silverberg, Joel Petersson & Paul Rutgeerts. (2014) Future directions in inflammatory bowel disease management. Journal of Crohn's and Colitis 8:8, pages 726-734.
Crossref
Crossref
K. Subramaniam, A. Richardson, J. Dodd, J. Platten, B. Shadbolt & P. Pavli. (2014) Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy. Internal Medicine Journal 44:5, pages 464-470.
Crossref
Crossref
Shomron Ben-Horin & Yehuda Chowers. (2014) Tailoring anti-TNF therapy in IBD: drug levels and disease activity. Nature Reviews Gastroenterology & Hepatology 11:4, pages 243-255.
Crossref
Crossref
Yi Fengming & Wu Jianbing. (2014) Biomarkers of Inflammatory Bowel Disease. Disease Markers 2014, pages 1-11.
Crossref
Crossref
Marc Ferrante, Séverine Vermeire, Gert Van Assche & Paul Rutgeerts. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis
175
184
.
Maria K Magnusson, Rahil Dahlén, Hans Strid, Stefan Isaksson, Magnus Simrén, Anders Lasson, Antal Bajor, Kjell‐Arne Ung & Lena Öhman. (2013) CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis. United European Gastroenterology Journal 1:6, pages 467-476.
Crossref
Crossref
David J. Gibson, Elizabeth J. Ryan & Glen A. Doherty. (2013) Keeping the Bowel Regular. Inflammatory Bowel Diseases 19:12, pages 2716-2724.
Crossref
Crossref
R. Dahlén, H. Strid, A. Lundgren, S. Isaksson, S. Raghavan, M. K. Magnusson, M. Simrén, H. Sjövall & L. Öhman. (2013)
Infliximab Inhibits Activation and Effector Functions of Peripheral Blood T Cells
in vitro
from Patients with Clinically Active Ulcerative Colitis
. Scandinavian Journal of Immunology 78:3, pages 275-284.
Crossref
Crossref
ZHAOGANG DONG, LUTAO DU, XIAOFEI XU, YONGMEI YANG, HAIYAN WANG, AILIN QU, XUN QU & CHUANXIN WANG. (2013) Aberrant expression of circulating Th17, Th1 and Tc1 cells in patients with active and inactive ulcerative colitis. International Journal of Molecular Medicine 31:4, pages 989-997.
Crossref
Crossref